Development of the new cancer preventing method with the ingredient of the food of Kyoto
Development of the new cancer preventing method with the ingredient of the food of Kyoto
批准号:
12794011
负责人:
SAKAI Toshiyuki
金额:
$25.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for University and Society Collaboration
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We showed clearly that the vitamin D_3 which is considered to have a preventive effect on colon cancer and prostatic cancer, etc, contained in the mushroom used abundantly at the food of Kyoto, activates the p27 gene promoter through its Sp1 and CCAAT binding sites by the transcription factors Sp1 and NF-Y, and not through the vitamin D_3 receptor-binding site.Vitamin D_3 also activates mac25, gene, which is known to compensate for the function of tumor-suppressor gene p53.The dietary fiber, which is contained in the root crop used in the food of Kyoto, is metabolized to butyrate. We showed clearly that the butyrate activates the gadd45 gene promoter, in p53-independent manner, through its Oct-1 and CCAAT binding sites by the transcription factors Oct-1 and NF-Y.We searched for another drugs which can activate gadd45 gene promoter from the ingredients of food, such as flavonoids contained in the Kyoto vegetable, green tea, etc., and found that quercetin which is a kind of flavonoid activates gadd45 gene in p53-independent manner. Although this activation was seen in the mRNA level, there was no change in promoter activity. It has suggested that the mechanism of activation of gadd45 gene is different between butyrate and quercetin.Using about 16 gene promoters we have (eg. cell cycle-regulating genes, apoptosis related genes), the promoter-activating drug was searched and some interesting drugs were found out. These drugs are expected to become new cancer preventive drugs.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sowa, Y., Sakai, T.: "Butyrate as a model for "gene-regulating chemoprevention and chemotherapy""Biofactors. 12. 283-287 (2000)
Sowa, Y., Sakai, T.:“丁酸盐作为“基因调节化学预防和化疗”的模型”生物因子。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsukawa, Y., Nishino, H., Yoshida, U., Sugihara, H., Katsura, K., Takamatsu, T., Okuzumi, J., Matsumoto, K., Sato-Nishimori, F., Sakai, T.: "Quercetin enhances tumorigenicity induced by N-Ethyl-N'-Nitro-N-Nitrosoguanidine in the duodenum of mice"Environ
松川 Y.、西野 H.、吉田 U.、杉原 H.、桂 K.、高松 T.、奥住 J.、松本 K.、佐藤西森 F.、酒井 T
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Maeda,A., Yoshida,T., Kusuzaki,K., and Sakai,T.: "The characterization of the human Siah-1 promoter"FEBS Letters. 512. 223-226 (2002)
Maeda,A.、Yoshida,T.、Kusuzaki,K. 和 Sakai,T.:“人类 Siah-1 启动子的表征”FEBS Letters。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshida, T., Maeda, A., Tani, N., Sakai, T.: "Promoter structure and transcription initiation sites of the human Death Receptor 5/TRAIL-R2 gene"FEBS Letters. 507. 381-385 (2001)
Yoshida, T.、Maeda, A.、Tani, N.、Sakai, T.:“人类死亡受体 5/TRAIL-R2 基因的启动子结构和转录起始位点”FEBS Letters。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
酒井敏行: "がん化学予防の最前線.西野輔翼編"大阪:医療ジャーナル社. 106 (2000)
酒井俊之:“癌症化学预防的最前沿。西野辅编”大阪:医学杂志有限公司106(2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 38 条
Application of molecular-targeting cancer prevention to human intervention study.
-
批准号:15H02529
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$29.29万
-
财政年份:2015
-
负责人:SAKAI Toshiyuki
-
依托单位:
Novel molecular-targeting prevention of cancer by sensitizing the effect of sodium butyrate
-
批准号:23659336
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:SAKAI Toshiyuki
-
依托单位:
Development of micrRNA-targeting cancer prevention
-
批准号:21249042
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$28.29万
-
财政年份:2009
-
负责人:SAKAI Toshiyuki
-
依托单位:
Research on a selection reference of chemopreventive agents for cancer and a development of tailor-made medicine for cancer prevention
-
批准号:17209022
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.87万
-
财政年份:2005
-
负责人:SAKAI Toshiyuki
-
依托单位:
Basic research for ‘gene-regulating chemoprevention' by using food factors
-
批准号:14370126
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2002
-
负责人:SAKAI Toshiyuki
-
依托单位:
Development of specific prevention against DNA damage caused by environment
-
批准号:11557031
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:1999
-
负责人:SAKAI Toshiyuki
-
依托单位:
Development of specific prevention against people with high susceptibility for cancer and general carcinogenesis
-
批准号:10470097
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:1998
-
负责人:SAKAI Toshiyuki
-
依托单位:
Activation of extrinsic coagulation on tumor cell
-
批准号:02670457
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1990
-
负责人:SAKAI Toshiyuki
-
依托单位:
A Study for fusion with Pattern Recognition and Artificial Intelligence in the hierarchical structures
-
批准号:62420035
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$5.06万
-
财政年份:1987
-
负责人:SAKAI Toshiyuki
-
依托单位:
Developmental Research of Drawing Image Processor for Translation, Automatic Transformation and Fair Printing
-
批准号:60850064
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$13.25万
-
财政年份:1985
-
负责人:SAKAI Toshiyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
UBE2D2负调控p27抑制细胞衰老促进胶质瘤进展的机制研究
-
批准号:2026JJ80431
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙学志
-
依托单位:
基于p27(KIP1)的磷酸化和亚细胞定位探讨周围神经修复机制及中药干预研究
-
批准号:2025JJ80967
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李洪辉
-
依托单位:
p27介导细胞铁死亡改善卵巢癌铂耐药的作用及机制研究
-
批准号:JCZRYB202500413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
衰老性 Lamin A-Sirt6-P27 在衰老性脂肪组织
再分布中的作用研究
-
批准号:Q24H070004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨甜
-
依托单位:
E3泛素连接酶RNF6促进p27的泛素化降解影响胶质母细胞瘤的增殖和化疗敏感性
-
批准号:82103156
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:侯建兵
-
依托单位:
Ambra1通过Akt磷酸化FoxO1抑制p27转录促进乳腺癌细胞增殖和肿瘤发生的机制研究
-
批准号:82160499
-
项目类别:地区科学基金项目
-
资助金额:34.1万元
-
批准年份:2021
-
负责人:孙蔚亮
-
依托单位:
CDK2/p27/SKP2网络对视网膜母细胞瘤Y79细胞株c-MYC蛋白影响的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:
-
依托单位:
MLF1IP通过BRCA1/AKT/p27信号轴促进结直肠癌细胞增殖的机制研究
-
批准号:82002919
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐玉婷
-
依托单位:
SIRT2/TGF/smad/p27通路表观调控特发性肺纤维化的机制
-
批准号:2020JJ5802
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:段娟
-
依托单位:
p27上调PHLPP1改善卵巢癌铂耐药的机制研究
-
批准号:82002771
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:彭明刚
-
依托单位: